Andy Choi

Andy has over 20 years of experience in product development and commercialization with expertise in the medical device industry. He has held executive positions ranging from engineering to marketing and sales in start-up settings to Fortune 500 companies. As a VP of R&D, Andy introduced a pioneering minimally invasive technology that enabled interventional physicians to surgically treat lumbar spinal stenosis. He also led the asset sale of a spinal fusion device to Stryker, which achieved a 10x return in less than a year from concept to commercialization. For almost 10 years, Andy held positions in both marketing and engineering with Stryker Spine and Orthopedics. As a Business Director and Chief Engineer, he led the development and commercialization of numerous flagship products ranging in Minimally Invasive Systems to Surgical Navigation. In 2007, he was showcased in the Stryker Corporation Annual Report for his contribution in developing and launching the Xia 3 Spinal Fusion System, which achieved $200 million in global sales in the first year. Andy is an author of multiple US and international patents. Andy earned his B.S. in Mechanical Engineering from U.C. Berkeley and received his MBA from Rutgers University. He also completed executive education program from the Wharton School of the University of Pennsylvania.